Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Clinical trial NCT07034326 · RECRUITING

Trial details

NCT number: NCT07034326
Sponsor: Kong Fanming
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Electroacupuncture Immune Checkpoint Inhibitors

Start date: 2025-01-01
Primary completion: 2028-12-31
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.